Skip to main content
. 2023 Apr 18;72(10):1919–1926. doi: 10.1136/gutjnl-2022-327955

Table 3.

Pancreatitis outcome stratified by underlying biliary entity

Sludge-AP (n=50) Microlithiasis-AP (n=43) Gallstone-AP (n=84) P value
Severity (RAC), N (%) 0.40
 Mild 27 (54.0) 29 (67.44) 42 (50.0)
 Moderate 18 (36.0) 10 (23.25) 34 (40.47)
 Severe 5 (10.0) 4 (9.3) 8 (9.52)
SIRS at admission, N (%) 4 (8.0) 2 (4.65) 11 (13.09) 0.28
SIRS at hospital stay, N (%) 8 (16) 5 (11.62) 16 (19.04) 0.56
Length of hospital stay (mean±SD in days) 14.7±17.15 13.14±10.68 12.31±11.45 0.59
IMC stay, N (%) 5 (10.0) 9 (20.1) 17 (20.23) 0.25
ICU stay, N (%) 5 (10.0) 3 (6.9) 8 (10.0) 0.79
ERCP, N (%) 18 (36) 20 (46.51) 46 (54.76) 0.18
Concrement extraction rate, N (%) 15 (75.0) 12 (54.5) 35 (72.9) 0.24
Post-ERCP pancreatitis rate 0/18 (0) 2/20 (10) 0/84 (0) 0.64
Mortality, N (%) 0 (0.0) 0 (0.0) 1 (1.19) 0.57
Cholecystectomy
 Yes 21 (42.0) 25 (58.13) 46 (54.76) 0.10
 No 24 (48.0) 11 (25.58) 23 (27.38)
 Unknown 5 (10.0) 7 (16.27) 15 (17.85)

AP, acute pancreatitis; ERCP, endoscopic retrograde cholangiopancreatography; ICU, intensive care unit; IMC, intermediate care unit ; RAC, revised Atlanta classification; SIRS, systemic inflammatory response syndrome.